CDCA7L Antibody (OTI3B5) NBP2-46198 from Novus Biologicals, a Bio-Techne Brand

Product Specs
ItemCDCA7L Antibody (OTI3B5)
CompanyNovus Biologicals, a Bio-Techne Brand
Price $459.00Supplier Page View Company Product Page
Catalog NumberNBP2-46198
PurityImmunogen affinity purified
Molecular Weight52 kDa
Concentration1 mg/ml
StorageStore at -20C. Avoid freeze-thaw cycles
NCBI Full Gene Namecell division cycle associated 7 like
NCBI Gene AliasesJPO2, R1, RAM2
Research AreaApoptosis, Cancer, Cell Biology
Antibody TypePrimary Antibodies
ReactivityHuman (Hu)
ClonalityMonoclonal
ApplicationsWB, IHC, IHC-p
ImmunogenHuman recombinant protein fragment corresponding to amino acids 1-337 of human CDCA7L (NP_061189) produced in E.coli
HostMouse
CloneOTI3B5
IsotypeIgG1
TargetCDCA7L
FormatPBS (pH 7.3), 1.0% BSA and 50% Glycerol
Conjugate/TagUnconjugated
Quantity0.1 ml

Available conjugates: Available conjugates: Unconjugated

Sizes Available: 0.1 ml

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

(1) "The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells"CellsJanuary 1, 0001"Ortiz-Hernandez GL, Sanchez-Hernandez ES, Ochoa PT, Elix CC, Alkashgari HR, McMullen JRW, Soto U, Martinez SR, Diaz Osterman CJ, Mahler M, et al."ASK1 (Abnova, Walnut, CA, USA Cat# H00010926-M01) JPO2 (Novus Biologicals, Centennial, CO, USA, Cat# NBP2-46198); and horseradish peroxidase (HRP)-conjugated anti-β-actin (Cell Signaling Technologies, Cat# 12620).

CDCA7L Antibody (OTI3B5)